Search Market Research Report
Biochips Market Size, Share Global Analysis Report, 2020–2026
Biochips Market By Product (Protein Chip, Lab-on-a-chp, DNA Chip, and Others), Application (Drug Development & Discovery, Disease Diagnostics, Agriculture, Genomics, Proteomics, and Others), and End User (Diagnostics, Centers, Hospitals, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, and Others)and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026
Industry Insights
The biochips market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire biochips market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volume (Units) and value (USD Million) from FY 2016 – 2026.
This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the biochips industry. The report analyzes and declares the historical and current trends analysis of the biochips industry and subsequently recommends the projected trends anticipated to be observed in the biochips market during the upcoming years.
Key Insights from Primary Research
- As per our primary respondents, the global biochips market is set to grow annually at a rate of around 11%
- It was established through primary research that the global biochips market was valued at around 11 USD billion in 2019
- The “The drug development & discovery” category, on the basis of application segmentation, is expected dominate in terms of revenue, over the forecast period
- Based on the region, North America is expected to account for the revenue share in 2019 in the target market
Key Recommendations from Analysts
- As per our analysts, global biochips are growing at high CAGR and various end-use industries are aware of this potential market and applications of biochips
- Growing at a CAGR around 11.28%, global biochips market provides numerous opportunities for all of the involved stakeholders across the entire value chain
- Our analysts have identified DNA chip are dominating segment for global biochips market in terms of product segmentation
Market Share – By Product
The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the biochip industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.
Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the biochips industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the biochips market.
The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders in the biochips involved in the entire value chain of the biochips industry. The market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.
The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the biochips sector. Key strategic developments in the biochips market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the biochips market are appropriately highlighted in the report.
The biochips market research report delivers an acute valuation and taxonomy of the biochip industry by practically splitting the market on the basis of different products, applications, end-user, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the biochip industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the biochips industry is provided for the leading economies of the world.
Increasing demand for personalized medicine across the globe, coupled with technological advancements in this field are major factors driving the growth of the global biochips market. Additionally, growing applications of biochips in various end-use sectors is another factor to propel the growth of the global market in the near future. However, the high costs associated with the instruments are hampering the growth of the global market.
The global biochips market has been segmented on the basis of application, product type, and end-user. On the basis of the application segment, the global market can be bifurcated into drug development & discovery, disease diagnostics, agriculture, genomics, proteomics, and others. The product type segment is classified as protein chip, DNA chip, lab-on-a-chip, and others. On the basis of the end-user segment, the global market is divided into pharmaceutical & biotechnology companies, hospitals, research & academic institutes, diagnostics centers, and other end-users.
The taxonomy of the Biochips Market by its scope and segmentation is as follows:
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 11.02 Billion |
Projected Market Size in 2026 |
USD 23.29 Billion |
CAGR Growth Rate |
11.28% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
PerkinElmer, QIAGEN N.V., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Bio-Rad Laboratories, Illumina, Inc., F. Hoffmann-La Roche AG, HORIBA, Ltd., bioMérieux SA, Fluidigm Corporation , and others. |
Key Segment |
By Product, Application, By End User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Analysis
- PerkinElmer
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Randox Laboratories Ltd.
- Bio-Rad Laboratories
- Illumina Inc.
- F. Hoffmann-La Roche AG
- HORIBA Ltd.
- bioMérieux SA
- Fluidigm Corporation
- and others
By Product Segmentation Analysis (Customizable)
- Lab-on-a-chip
- Protein Chip
- DNA Chip
- Others
By Application Segmentation Analysis (Customizable)
- Disease Diagnostics
- Drug Development & Discovery
- Proteomics
- Agriculture
- Genomics
- Others
By End User Segmentation Analysis (Customizable)
- Hospitals
- Diagnostics Centres
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Others
Regional Segmentation Analysis (Customizable)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
Industry Major Market Players
- PerkinElmer
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Randox Laboratories Ltd.
- Bio-Rad Laboratories
- Illumina Inc.
- F. Hoffmann-La Roche AG
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors